Seldar Pharma, Inc. — Form D/A
Seldar Pharma, Inc. of BRIDGEWATER, NJ, a company, filed a Form D amendment with the SEC on 2013-12-11. The offering totals $13.0M, of which $13.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-12-11
- Form: D/A
- Accession: 0000897069-13-000416
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $13.0M
- Amount sold: $13.0M
- Investors: 22
- Date of first sale: 2012-05-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-179783
Issuer
- Name: Seldar Pharma, Inc.
- CIK: 0001552224
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 520 US HIGHWAY 22, BRIDGEWATER, NJ, 08807
- Phone: (908) 895-1200
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Jeffrey L Bird | Director | Palo Alto, CA |
| Robert L Desjardins | Director | Bridgewater, NJ |
| Arnold L Oronsky | Director | Baltimore, MD |
| Donna L Tempel | Director | Bridgewater, NJ |
| Christopher L Del Mastro | Executive Officer | Bridgewater, NJ |
| Robert L Desjardins | Executive Officer | Bridgewater, NJ |
| Donna L Tempel | Executive Officer | Bridgewater, NJ |
| Robert L Desjardins | Promoter | Bridgewater, NJ |
| Donna L Tempel | Promoter | Bridgewater, NJ |
Other filings by this issuer (1)
More